HRCM
KMTS

Hood River Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Hood River Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1M Buy
655,877
+95,420
+17% +$2.25M 0.13% 124
2025
Q4 		$14.9M Buy
560,457
+165,219
+42% +$4.26M 0.16% 117
2025
Q3 		$9.39M Buy
+395,238
New +$7.07M 0.11% 126

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hood River Capital Management's KMTS Position: Q1 2026 in Review

Hood River Capital Management increased its Kestra Medical Technologies (KMTS) stake by 17% in Q1 2026, buying an estimated $2.25M and bringing the position to 655,877 shares worth $13.1M. The position accounts for 0.13% of the portfolio, ranked #124.

Hood River Capital Management first reported a position in KMTS in Q3 2025 and has held it in 3 quarters since. The position peaked at $14.9M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Hood River Capital Management held 655,877 shares of Kestra Medical Technologies worth $13.1M as of Q1 2026.
  • Hood River Capital Management bought 95,420 Kestra Medical Technologies shares in Q1 2026, an estimated $2.25M.
  • Kestra Medical Technologies made up 0.13% of Hood River Capital Management's portfolio in Q1 2026, its #124 holding.
  • Hood River Capital Management first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 3 quarters since.
  • Hood River Capital Management's Kestra Medical Technologies position peaked at $14.9M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Hood River Capital Management's 13F filing for Q1 2026, filed 15 May 2026.